Transcutaneous delivery of disease specific PI3K/Akt/mTOR inhibitor based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies
Roshan Keshari, Rupali Bagale, Sulagna Rath, Abhijit De, Rinti Banerjee, Shamik Sen, Rohit Srivastava
This paper develops a hybrid nanoparticle-hydrogel system for psoriasis treatment, showing improved drug delivery and reduced PASI scores in vivo.
International Journal of Pharmaceutics · Feb 13, 2025Peer-reviewedPharmacology & Toxicology